Back to Envestnet Portfolio Solutions, Inc. Envestnet Portfolio Solutions, Inc.

NKTRNKTR
4 quarters

Position history for Envestnet Portfolio Solutions, Inc.Envestnet Portfolio Solutions, Inc.'s holdings in Nektar Therapeutics

Envestnet Portfolio Solutions, Inc. previously held 0 shares of NKTR (Nektar Therapeutics), worth $0 as of 2024-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$23,601

Total Shares Change

-39,626

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%$18.60
0
2024-Q1
Decreased
11,686
-58.2%
$10,9170.0%$13.95
0
2023-Q4
Decreased
27,941
-29.5%
$15,7870.0%$8.40
0
2023-Q3
New
39,626
-
$23,6010.0%$9.00
26

Other major holders of NKTR: BNP PARIBAS FINANCIAL MARKETS, Invesco Ltd., PRIMECAP MANAGEMENT CO/CA/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used